. . . . . . . . . . . . "[In this article entitled How many JAK inhibitors for myelofibrosis we discuss JAK2 as a target, review briefly the benefits to patients with MF of JAK inhibition and highlight some of the differences between the number of JAK inhibitors currently being evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:50:57+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .